The global noise level provides an accurate, robust, and automated method to measure CT noise in clinical examinations for quality assurance programs. The significant difference in noise across scanner models indicates the unexploited potential to efficiently assess and subsequently improve protocol consistency. Combined with other automated characterization of imaging performance (e.g., dose monitoring), the global noise level may offer a promising platform for the standardization and optimization of CT protocols.

This paper reports on the methodology and materials used to construct anthropomorphic phantoms for use in dosimetry studies, improving on methods and materials previously described by Jones et al. [Med Phys. 2006;33(9):3274–82]. To date, the methodology described has been successfully used to create a series of three different adult phantoms at the University of Florida (UF). All phantoms were constructed in 5 mm transverse slices using materials designed to mimic human tissue at diagnostic photon energies: soft tissue‐equivalent substitute (STES), lung tissue‐equivalent substitute (LTES), and bone tissue‐equivalent substitute (BTES). While the formulation for BTES remains unchanged from the previous epoxy resin compound developed by Jones et al. [Med Phys. 2003;30(8):2072—81], both the STES and LTES were redesigned utilizing a urethane‐based compound which forms a pliable tissue‐equivalent material. These urethane‐based materials were chosen in part for improved phantom durability and easier accommodation of real‐time dosimeters. The production process has also been streamlined with the use of an automated machining system to create molds for the phantom slices from bitmap images based on the original segmented computed tomography (CT) datasets. Information regarding the new tissue‐equivalent materials, as well as images of the construction process and completed phantom, are included.PACS number: 87.53.Bn

Matching image appearance in terms of resolution, noise magnitude, and noise texture provides a quantitative and reproducible strategy to improve consistency in image quality among different CT scanners and reconstructions.

As recent Monte Carlo simulations have shown, there exists an inherent uncertainty when performing dose measurements within a phantom during helical MDCT scans. The periodic dose distributions in helical MDCT means that low resolution sampling of local phantom doses could result in dose measurement aliasing. For reliable results, these considerations should be accounted for in helical MDCT phantom dosimetry studies. The variability in surface dose has a strong dependence on phantom positioning relative to isocenter. Dose to tissues such as the lens of the eye and thyroid can be minimized by positioning patients, so these tissues are closer to isocenter because the decrease in x-ray intensity due to beam divergence dominates the increases resulting from increased primary beam exposure overlap. Of course, this dose decrease would have to be balanced against any diminished image quality resulting from misalignment of the patient with the bowtie filter. Additionally, significantly reduced dose to small radiosensitive tissues such as the lens of the eye could occur if it were possible to shift the phase of the periodic dose distribution present in helical MDCT. These dose reductions would come at no cost to image quality.

In helical computed tomography (CT), reconstruction information from volumes adjacent to the clinical volume of interest (VOI) is required for proper reconstruction. Previous studies have relied upon either operator console readings or indirect extrapolation of measurements in order to determine the over‐ranging length of a scan.( 1 – 5 ) This paper presents a methodology for the direct quantification of over‐ranging dose contributions using real‐time dosimetry. A Siemens SOMATOM Sensation 16 multislice helical CT scanner is used with a novel real‐time “point” fiber‐optic dosimeter system with 10 ms temporal resolution to measure over‐ranging length, which is also expressed in dose‐length‐product (DLP). (6) Film was used to benchmark the exact length of over‐ranging. Over‐ranging length varied from 4.38 cm at pitch of 0.5 to 6.72 cm at a pitch of 1.5, which corresponds to DLP of 131 to 202 mGy‐cm. The dose‐extrapolation method of Van der Molen et al. yielded results within 3%, while the console reading method of Tzedakis et al.( 2 , 4 ) yielded consistently larger over‐ranging lengths. From film measurements, it was determined that Tzedakis et al.( 2 , 4 ) overestimated over‐ranging lengths by one‐half of beam collimation width. Over‐ranging length measured as a function of reconstruction slice thicknesses produced two linear regions similar to previous publications.( 1 – 4 ) Over‐ranging is quantified with both absolute length and DLP, which contributes about 60 mGy‐cm or about 10% of DLP for a routine abdominal scan. This paper presents a direct physical measurement of over‐ranging length within 10% of previous methodologies.( 1 – 4 ) Current uncertainties are less than 1%, in comparison with 5% in other methodologies. Clinical implantation can be increased by using only one dosimeter if codependence with console readings is acceptable, with an uncertainty of 1.1% This methodology will be applied to different vendors, models, and postprocessing methods – which have been shown to produce over‐ranging lengths differing by 125%. (4) PACS number: 87.57.qp

No abstract

Purpose: To develop pediatric CT protocols by characterizing effects of CT parameters on adult and pediatric CT dose using automatic tube‐current modulation (ATCM). Method and Materials: Adult and 10‐year‐old (10yo) ATOM (CIRS) phantoms were scanned on a 16‐channel CT system (Emotion 16, Siemens) using ATCM (CareDose4D) to characterize the relationships between CT scan parameters and patient dose. The scan parameters investigated include scan‐kVp, reference‐mAs, scout‐kVp, patient‐size selection (adult/pediatric), and rotation‐time. Effective‐mAs delivered by ATCM was extracted from the DICOM header of each CT image. Results: Effective‐mAs delivered by ATCM varied with patient‐size selection, relative to reference‐mAs, it decreased for adult but increased for pediatric. Using ATCM the average effective‐mAs for 80, 100, 130 scan‐kVp changed by 81%&124%, 61%&110%, 55%&103% relative to reference‐mAs for the adult&10yo phantoms. However, when the 10yo was selected as adult, the average effective‐mAs decreased to 34%, 29%, and 26% of reference‐mAs. When selected as adult, dose decreased for all anatomical regions but when selected as pediatric, dose increase was observed for abdomen and pelvis (120–155%). ATCM effective‐mAs per slice scaled linearly (1±0.06) with input reference‐mAs. However, the minimum mA limited the modulation of effective‐mAs at low reference‐mAs. For both phantoms, 80 kVp scouts reduced the effective‐mAs by 5–7% on average (up to 20% for thorax) compared to 130 kVp scouts. For identical reference‐mAs, ATCM increased effective‐mAs for lower scan‐kVp; however, patient dose also decreased for lower scan‐kVp. For the adult&10yo phantoms, average dose at 80 and 110 scan‐kVp was 42%&39% and 72%&72% of that at 130 scan‐kVp, respectively. Conclusion: Patient dose with ATCM decreased for adult and increased for pediatric patients. The scout‐kVp affects ATCM schema with lower effective‐mAs for lower scout‐kVp. ATCM effective‐mAs is linear with input reference‐mAs. Net patient dose is reduced despite increased effective‐mAs at lower scan‐kVp using ATCM.

No abstract